| Date | Form | Description | Docs | XBRL | Pages |
| 08/21/19 | 8-K | Current report filing |
|
25 | |
| 07/18/19 | 8-K | Current report filing |
|
4 | |
| 06/21/19 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/19/19 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 06/18/19 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/12/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 06/11/19 | S-3 | Registration statement for specified transactions by certain issuers |
|
137 | |
| 05/23/19 | 8-K | Current report filing |
|
25 | |
| 05/02/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...